Literature DB >> 16414246

Genotype analysis of Candida albicans isolates obtained from different body locations of patients with superficial candidiasis using PCRs targeting 25S rDNA and ALT repeat sequences of the RPS.

Hisao Hattori1, Takako Iwata, Yoshiyuki Nakagawa, Fumihiko Kawamoto, Yasushi Tomita, Akihiko Kikuchi, Toshio Kanbe.   

Abstract

BACKGROUND: Several molecular biology-based genotyping techniques have been adapted for studying the molecular characteristics of Candida albicans strains, which constitute the majority of the etiologic agents in candidiasis. Recently, we reported a PCR system targeting 25S rDNA and ALT repeat sequences in the repetitive sequence (RPS) for genotyping of C. albicans.
OBJECTIVE: To assess the potential of 25S rDNA and RPS-based genotyping for studying the molecular epidemiology of C. albicans, and define the genotypic relationship of C. albicans between invasive and non-invasive lesions in the same individual.
METHODS: C. albicans strains were isolated from infected lesions and commensal sites, such as oral mucosa and/or feces, of patients with superficial candidiasis. The genomic DNAs were amplified by PCRs using P-I and P-II to determine the 25S rDNA- and RPS-based genotypes of the isolates.
RESULTS: Genotype A:3 C. albicans constituted the majority of the isolates, followed by A:3/4 and B:3 C. albicans. There was usually one genotype of C. albicans per person. The genotypes of infected lesion isolates and non-infected oral mucosa and/or feces isolates were identical in the same individual, even in serially isolated C. albicans.
CONCLUSION: The results indicate that our combined PCR technique using P-I and P-II is a potential tool for molecular typing of C. albicans, and reveal that the genotypes of isolates are identical in the same individual, independent of the infective and non-infective phases or the body location.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16414246     DOI: 10.1016/j.jdermsci.2005.12.003

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  7 in total

1.  Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study.

Authors:  R H Jensen; H K Johansen; L M Søes; L E Lemming; F S Rosenvinge; L Nielsen; B Olesen; L Kristensen; E Dzajic; K M T Astvad; M C Arendrup
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

2.  Repetitive sequences based on genotyping of Candida albicans isolates obtained from Iranian patients with human immunodeficiency virus.

Authors:  Iradj Ashrafi Tamai; Taghi Zahraei Salehi; Aghil Sharifzadeh; Hojjatollah Shokri; Ali Reza Khosravi
Journal:  Iran J Basic Med Sci       Date:  2014-11       Impact factor: 2.699

Review 3.  Molecular approaches in the diagnosis of dermatophytosis.

Authors:  Toshio Kanbe
Journal:  Mycopathologia       Date:  2008-05-15       Impact factor: 2.574

4.  Genotyping of Candida albicans isolated from animals using 25S ribosomal DNA and ALT repeats polymorphism in repetitive sequence.

Authors:  Armina Dalvand; Farzad Katiraee; Raziallah Jafari Joozani; Hojjatolah Shokri
Journal:  Curr Med Mycol       Date:  2018-12

5.  Surveillance of the prevalence, antibiotic susceptibility, and genotypic characterization of invasive candidiasis in a teaching hospital in China between 2006 to 2011.

Authors:  Fang Li; Lin Wu; Bin Cao; Yuyu Zhang; Xiaoli Li; Yingmei Liu
Journal:  BMC Infect Dis       Date:  2013-07-30       Impact factor: 3.090

6.  Influence of Culture Media on Microbial Fingerprints Using Raman Spectroscopy.

Authors:  Katarína Mlynáriková; Ota Samek; Silvie Bernatová; Filip Růžička; Jan Ježek; Andrea Hároniková; Martin Šiler; Pavel Zemánek; Veronika Holá
Journal:  Sensors (Basel)       Date:  2015-11-24       Impact factor: 3.576

7.  Genotype Analysis of Clinical Candida albicans Isolates Using PCRs Targeting 25S rDNA and ALT Repeat Sequences of the RPS and Antifungal Susceptibility in Ouagadougou (Burkina Faso).

Authors:  Patindoilba Marcel Sawadogo; Adama Zida; Issiaka Soulama; S Samuel Sermé; Kiswendsida Thierry Guiguemdé; Richard Junior; Ibrahim Sangaré; Sanata Bamba; Rasmata Ouédraogo-Traoré; Tinga Robert Guiguemdé
Journal:  Infect Drug Resist       Date:  2019-12-16       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.